Ocular Therapeutix (OCUL) Stock: Buy, Sell, or Hold?
OCUL - Ocular Therapeutix, Inc.
$10.49
-0.13 (-1.22%)
âŧ
5d:
-1.41%
30d:
+2.54%
90d:
+20.57%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 10, 2026 at $10.62 · last confirmed Sep 11, 2026
Strength: 5.7/10
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OCUL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OCUL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $10.49, which is considered fair relative to its 30-day fair value range of $9.42 to $11.21.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $10.13, while resistance sits at $11.48.
Market Sentiment: OCUL scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.09 (+158.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $10.13, while resistance sits at $11.48.
Market Sentiment: OCUL scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $27.09 (+158.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$9.42 -
$11.21
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding OCUL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (37/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 158.3% below Wall St target ($27.09)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.42 -
$11.21
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.13
Resistance Level
$11.48
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.21
Wall Street Target
$27.09
(+158.3%)
Revenue Growth (YoY)
0.1%
Share & Embed Analysis
Last updated: September 12, 2026 5:48 AM ET
Data refreshes hourly during market hours. Next update: 6:48 AM
Data refreshes hourly during market hours. Next update: 6:48 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
